Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the study of psoriasis, rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
Purity:
>95%
CAS Number:
[339308-60-0]
Target:
IL Receptor|||Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted